Stock listing
Hamburg:B1Q NRX Pharmaceuticals, Inc. Aktie
German listing (Hamburg) of NRX Pharmaceuticals, Inc. · home listing NASDAQ:NRXP
Follow NRX Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:NRXP
$2.27 USD -0.39 (-14.7%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:NRXP
- Day range
- $2.11 – $2.84 USDOct 30, 2026
- Volume
- 15.54M sharesOct 30, 2026
- Market cap
- $98.28M USDAt the close on Oct 30, 2026 · price × 43.30M shares outstanding
- 52-week range
- $1.62 – $5.06 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $3.27M USDMedian day 714,835 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NRXP · Home | $2.27 USD | -0.39 (-14.7%) | 15,536,405 | $2.83 | $2.84 | $2.11 | $2.66 | Close on Oct 30, 2026 |
| Frankfurt:B1Q | €2.85 EUR | +0.565 (+24.7%) | — | €2.725 | €2.85 | €2.59 | €2.285 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:NRXP · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.27 | -0.39 | -14.7% | $2.83 | $2.84 | $2.11 | 15,536,405 | |
| $2.66 | -0.03 | -1.1% | $2.70 | $2.773 | $2.615 | 1,260,943 | |
| $2.69 | 0.00 | 0.0% | $2.73 | $2.745 | $2.64 | 834,658 | |
| $2.69 | +0.14 | +5.5% | $2.59 | $2.705 | $2.53 | 749,121 | |
| $2.55 | +0.06 | +2.4% | $2.48 | $2.59 | $2.459 | 594,730 | |
| $2.49 | +0.09 | +3.8% | $2.36 | $2.50 | $2.24 | 840,297 | |
| $2.40 | -0.23 | -8.7% | $2.57 | $2.61 | $2.36 | 1,051,688 | |
| $2.63 | +0.01 | +0.4% | $2.65 | $2.70 | $2.61 | 526,552 | |
| $2.62 | -0.01 | -0.4% | $2.63 | $2.77 | $2.545 | 1,348,553 | |
| $2.63 | +0.03 | +1.2% | $2.815 | $2.815 | $2.623 | 1,093,428 | |
| $2.60 | -0.11 | -4.1% | $2.70 | $2.76 | $2.572 | 1,226,911 | |
| $2.71 | +0.12 | +4.6% | $2.53 | $2.772 | $2.48 | 1,177,679 | |
| $2.59 | -0.11 | -4.1% | $2.64 | $2.705 | $2.56 | 696,336 | |
| $2.70 | -0.15 | -5.3% | $2.85 | $2.85 | $2.675 | 553,869 | |
| $2.85 | 0.00 | 0.0% | $2.85 | $2.93 | $2.815 | 481,039 | |
| $2.85 | -0.04 | -1.4% | $2.89 | $2.89 | $2.82 | 289,405 | |
| $2.89 | -0.01 | -0.3% | $2.88 | $2.895 | $2.805 | 651,765 | |
| $2.90 | -0.04 | -1.4% | $2.88 | $2.93 | $2.87 | 405,069 | |
| $2.94 | +0.07 | +2.4% | $2.89 | $2.975 | $2.825 | 418,910 | |
| $2.87 | -0.035 | -1.2% | $2.91 | $2.93 | $2.785 | 680,823 | |
| $2.905 | +0.055 | +1.9% | $2.91 | $2.94 | $2.82 | 613,067 | |
| $2.85 | -0.07 | -2.4% | $2.94 | $3.00 | $2.833 | 625,975 | |
| $2.92 | 0.00 | 0.0% | $3.035 | $3.06 | $2.91 | 1,172,268 | |
| $2.92 | +0.05 | +1.7% | $2.92 | $2.97 | $2.87 | 515,784 | |
| $2.87 | -0.125 | -4.2% | $2.95 | $3.01 | $2.87 | 736,822 | |
| $2.995 | -0.035 | -1.2% | $3.07 | $3.09 | $2.92 | 793,377 | |
| $3.03 | -0.13 | -4.1% | $3.15 | $3.15 | $3.025 | 681,052 | |
| $3.16 | -0.16 | -4.8% | $3.29 | $3.35 | $3.12 | 552,500 | |
| $3.32 | +0.03 | +0.9% | $3.30 | $3.33 | $3.21 | 495,041 | |
| $3.29 | -0.03 | -0.9% | $3.37 | $3.39 | $3.29 | 380,010 | |
| $3.32 | -0.07 | -2.1% | $3.38 | $3.42 | $3.31 | 947,272 | |
| $3.39 | +0.04 | +1.2% | $3.38 | $3.52 | $3.36 | 789,018 | |
| $3.35 | -0.05 | -1.5% | $3.39 | $3.45 | $3.32 | 716,043 | |
| $3.40 | -0.09 | -2.6% | $3.46 | $3.47 | $3.16 | 1,257,746 | |
| $3.49 | +0.09 | +2.6% | $3.37 | $3.605 | $3.35 | 1,205,425 | |
| $3.40 | 0.00 | 0.0% | $3.44 | $3.44 | $3.37 | 356,231 | |
| $3.40 | +0.03 | +0.9% | $3.36 | $3.45 | $3.32 | 480,116 | |
| $3.37 | -0.10 | -2.9% | $3.48 | $3.52 | $3.34 | 520,713 | |
| $3.47 | -0.02 | -0.6% | $3.50 | $3.54 | $3.42 | 705,974 | |
| $3.49 | +0.06 | +1.7% | $3.43 | $3.50 | $3.39 | 487,720 | |
| $3.43 | -0.03 | -0.9% | $3.48 | $3.50 | $3.425 | 237,362 | |
| $3.46 | +0.02 | +0.6% | $3.46 | $3.50 | $3.38 | 418,341 | |
| $3.44 | -0.04 | -1.1% | $3.45 | $3.51 | $3.42 | 392,760 | |
| $3.48 | -0.07 | -2.0% | $3.52 | $3.545 | $3.43 | 427,013 | |
| $3.55 | -0.07 | -1.9% | $3.63 | $3.68 | $3.50 | 695,596 | |
| $3.62 | +0.16 | +4.6% | $3.51 | $3.62 | $3.47 | 584,036 | |
| $3.46 | -0.21 | -5.7% | $3.62 | $3.62 | $3.38 | 1,011,362 | |
| $3.67 | +0.22 | +6.4% | $3.49 | $3.69 | $3.425 | 895,953 | |
| $3.45 | -0.11 | -3.1% | $3.52 | $3.61 | $3.44 | 898,336 | |
| $3.56 | +0.05 | +1.4% | $3.52 | $3.60 | $3.44 | 615,302 | |
| $3.51 | +0.18 | +5.4% | $3.36 | $3.55 | $3.33 | 811,738 | |
| $3.33 | -0.11 | -3.2% | $3.53 | $3.64 | $3.315 | 713,627 | |
| $3.44 | +0.01 | +0.3% | $3.39 | $3.47 | $3.28 | 905,074 | |
| $3.43 | +0.16 | +4.9% | $3.10 | $3.67 | $3.09 | 1,265,211 | |
| $3.27 | -0.07 | -2.1% | $3.37 | $3.40 | $3.155 | 1,128,895 | |
| $3.34 | -0.02 | -0.6% | $3.41 | $3.63 | $3.315 | 1,238,582 | |
| $3.36 | -0.04 | -1.2% | $3.40 | $3.50 | $3.29 | 927,898 | |
| $3.40 | +0.05 | +1.5% | $3.39 | $3.64 | $3.35 | 1,166,960 | |
| $3.35 | -0.23 | -6.4% | $3.51 | $3.64 | $3.31 | 1,996,331 | |
| $3.58 | +0.49 | +15.9% | $3.50 | $4.15 | $3.371 | 5,676,501 | |
| $3.09 | +0.035 | +1.1% | $3.06 | $3.18 | $3.03 | 552,115 | |
| $3.055 | +0.005 | +0.2% | $3.02 | $3.11 | $2.90 | 685,891 | |
| $3.05 | -0.19 | -5.9% | $3.30 | $3.32 | $2.94 | 1,256,699 | |
| $3.24 | +0.09 | +2.9% | $3.15 | $3.305 | $3.14 | 617,220 | |
| $3.15 | +0.03 | +1.0% | $3.16 | $3.30 | $2.95 | 1,147,529 | |
| $3.12 | -0.11 | -3.4% | $3.06 | $3.15 | $2.82 | 1,951,130 |
- Ticker
- Hamburg:B1Q
- Asset type
- Stock
- Exchange
- Hamburg
- Currency
- EUR
What changed lately
Latest news release · Oct 30, 2026
NRx Pharmaceuticals (Nasdaq: NRXP) Receives FDA Approval of Preservative-Free Ketamine Ahead of November 10 FDA Goal Date
Latest earnings call · Aug 17, 2026
NRX Pharmaceuticals (NASDAQ:NRXP) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Sep 14, 2026
Investor Presentation (September 2026)
Investor deck · 20 slides
Calls
Replays
NRX Pharmaceuticals (NASDAQ:NRXP) Q2 2026 Earnings Call
Mon, Aug 17, 2026 · 4:30 PM ET
Watch TranscriptNRX Pharmaceuticals (NASDAQ:NRXP) Q1 2026 Earnings Call
Mon, May 18, 2026 · 8:00 AM ET
Watch TranscriptNRX Pharmaceuticals (NASDAQ:NRXP) Q4 2025 Earnings Call
Tue, Mar 24, 2026 · 8:00 AM ET
Watch Transcript
Latest news
NRx Pharmaceuticals (Nasdaq: NRXP) Receives FDA Approval of Preservative-Free Ketamine Ahead of November 10 FDA Goal Date
Oct 30, 2026
Closed $2.27 (-14.7%) on Oct 30, 2026
NRx Pharmaceuticals (Nasdaq: NRXP) to Host Conference Call on October 30, 2026 to Discuss Regulatory Milestone for Preservative-Free Ketamine
Oct 29, 2026
Closed $2.27 (-14.7%) on Oct 30, 2026
NRx Pharmaceuticals (Nasdaq: NRXP) Announces Completion of Manufacturing Process Validation and Two-Year Stability of Preservative-Free Ketamine
Oct 19, 2026
Closed $2.63 (+1.2%) on Oct 19, 2026
NRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative-Free Ketamine
Oct 15, 2026
Closed $2.71 (+4.6%) on Oct 15, 2026
NRx Defense Systems, an NRx Company (Nasdaq: NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression
Sep 30, 2026
Closed $2.92 (0.0%) on Sep 30, 2026
NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine
Sep 15, 2026
Closed $3.40 (-2.6%) on Sep 15, 2026
GeNeuro, Inc., an NRx Company (Nasdaq: NRXP) is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral Sclerosis (ALS)
Sep 14, 2026
Closed $3.49 (+2.6%) on Sep 14, 2026
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System
Sep 11, 2026
Closed $3.40 (0.0%) on Sep 11, 2026
NRx Pharmaceuticals to Participate in Upcoming Investor Conferences
Sep 8, 2026
Closed $3.47 (-0.6%) on Sep 8, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 20 slides · Sep 14, 2026
Investor Presentation (June 2026)
Investor deck · 21 slides · June 2026
Investor Presentation (June 2023)
Investor deck · 34 slides · June 2023
Investor Presentation (January 2022)
Investor deck · 45 slides · January 2022
NRX Pharmaceuticals, Inc. on 6ix
- News releases
- 54 in the last 12 months · 273 in all · newest Oct 30, 2026 · oldest 2021
- Calls
- 20 calls with a replay · 20 with a transcript · latest Aug 17, 2026
- Decks
- 5 decks · latest Sep 14, 2026
Where NRX Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NRXP · Home listing | NASDAQ | United States | USD |
| LS Exchange:A4091K | LS Exchange | Germany | EUR |
| Lang & Schwarz:A4091K | Lang & Schwarz | Germany | EUR |
| BOATS:NRXP | BOATS | United States | USD |
| gettex:B1Q | gettex | Germany | EUR |
| Tradegate:B1Q | Tradegate | Germany | EUR |
| Frankfurt:B1Q | Frankfurt | Germany | EUR |
| Hamburg:B1Q · This page | Hamburg | Germany | EUR |
| Munich:B1Q | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about NRX Pharmaceuticals, Inc.